Bleomycins constitute a widely studied class of complex DNA cleaving natural products that are used to treat various cancers. Since their first isolation, the bleomycins have provided a paradigm for the development and discovery of additional DNA-cleaving chemotherapeutic agents. The bleomycins consist of a disaccharide-modified metal-binding domain connected to a bithiazole/Cterminal tail via a methylvalerate-Thr linker and induce DNA damage after oxygen activation through site-selective cleavage of duplex DNA at 5-GT/C sites. Here, we present crystal structures of two different 5-GT containing oligonucleotides in both the presence and absence of bound Co(III)⅐bleomycin B 2. Several findings from our studies impact the current view of bleomycin binding to DNA. First, we report that the bithiazole intercalates in two distinct modes and can do so independently of well ordered minor groove binding of the metal binding/disaccharide domains. Second, the Co(III)-coordinating equatorial ligands in our structure include the imidazole, histidine amide, pyrimidine N1, and the secondary amine of the ␤ aminoalanine, whereas the primary amine acts as an axial ligand. Third, minor groove binding of Co(III)⅐bleomycin involves direct hydrogen bonding interactions of the metal binding domain and disaccharide with the DNA. Finally, modeling of a hydroperoxide ligand coordinated to Co(III) suggests that it is ideally positioned for initiation of C4-H abstraction.
T
he bleomycins are a family of glycopeptide-derived antitumor natural products first isolated from Streptomyces verticillus by Umezawa (1) . Bleomycins are used to treat lymphomas (2, 3) and testicular cancers (4) , most often in combination therapies. The clinical efficacy of the bleomycins is thought to derive from their ability to mediate single-and double-strand DNA cleavage (5, 6) resulting from Fe 2ϩ and O 2 -dependent (7) C4Ј-H abstraction from pyrimidine nucleotides (8) contained within 5Ј-GT/C dinucleotide sites (9) . Of the DNA lesions formed, double-strand DNA cleavage is thought to be most relevant to the cytotoxicity of bleomycin. Although DNA is the generally accepted locus of drug activity, O 2 -activated Fe(II)⅐bleomycin also mediates the selective cleavage of RNA (10) , and Cu(I)⅐bleomycin is capable of cleaving DNA (11) ; however, the in vivo relevance of this alternative nucleic acid target and metal ion remain to be fully determined.
The metallobleomycins have served as an important paradigm for nucleic acid-targeted drug design (12, 13) ; and yet, despite extensive study over the past 40 years, fundamental aspects of their activity have yet to be fully defined including the role of particular DNA-binding modes on drug activity and the mechanism of double-strand DNA cleavage (14) . Facilitating structural studies, HOO-Co(III)⅐bleomycin ''green'' ( Fig. 1) (15) constitutes a stable structural analogue of O 2 activated Fe(II)⅐bleomycin, HOO-Fe(III)⅐bleomycin, that interacts with the same DNA site-selectivity (16) (17) (18) (19) (20) but requires photoactivation to cleave DNA. From 2D NMR derived models reported for DNA-bound HOO-Co(III)⅐bleomycin, the bithiazole is intercalated and the pyrimidinyl ring of the metal-binding domain interacts with the guanine of the 5Ј-GC site via the minor groove (21) (22) (23) (24) (25) . Although these studies have provided key information, the impact of drug binding on the substrate DNA structure has not been fully addressed. Here, we present the crystal structures of duplex DNA-bound HOO-Co(III)⅐bleomycin B 2 (Co⅐BLM) determined at 2.8 Å and 2.3 Å (PDB ID codes 2R2S and 2R2U), respectively, for DNA sequences 1 and 2 ( Fig. 1) . We also describe the structures of these same duplex DNAs in the absence of bound drug at 2.1 and 2.0 Å (PDB ID codes 2R2R and 2R2T) and discuss implications for recognition and cleavage of DNA by metallobleomycin.
Results
Description of the Structures. Crystal structures of Co⅐BLM bound to DNA were determined by using a host-guest system (26) (27) (28) (29) in which the N-terminal fragment of Moloney murine leukemia virus reverse transcriptase (RT), the ''host,'' is bound to the termini of d(ATTAGTTATAACTAAT) 2 (1) or d(ATTTAGT-TAACTAAAT) 2 (2) , each containing two preferred sites of drug binding, as the ''guests'' (Fig. 1) . The desired complexes were obtained through soaking Co⅐BLM (Fig. 1) into preformed RT-DNA crystals. Binding of Co⅐BLM was found to correlate with a change in the unit cell dimensions compared with unbound RT-DNA crystals [supporting information (SI) Text and Table S1 ]. No change in crystal color was observed after exposure to X-rays suggesting that the hydroperoxide ligand remained intact.
Of the two complexes, 1 displayed ordered density for the entire Co⅐BLM molecule excluding the hydroperoxide ligand and the propionamide, whereas 2 only exhibited ordered density for the intercalated bithiazole and a portion of the C-terminal tail. Co⅐BLM was found to occupy a 5-bp site in 1 including residues G 5 through T 7 and A 10 through A 14 on the complementary strand ( Figs. 1 and 2 ). The asymmetric unit of the RT-DNA crystals contains one molecule of the protein and 8 bp of the DNA before Co⅐BLM binding. After Co⅐BLM intercalation, the asymmetric unit for the drug complex includes one protein molecule, one Co⅐BLM, and 7.5 bp. To accommodate the intercalation of Co⅐BLM, which occupies the space of 1 bp, the adenines of the two A-T base pairs flanking the dyad are extruded, and a T-T base pair results (Figs. 1-3 ). This rearrangement at the dyad may be facilitated by breathing of A-T base pairs (30) and does not impact drug-DNA binding. The expected Co⅐BLM-induced changes in rise, helical twist, and minor groove width at the intercalation site and 5Ј GT recognition site are the most significant structural differences; otherwise, the overall structures of bound and unbound DNA are fairly similar despite the formation of the T-T base pair at the dyad (Fig. 3) . The first 6 bp of 1, including the 5Ј-GT site (A 1 -T 6 /T 6 -A 11 ) in the presence and absence of Co⅐BLM have an rmsd of 0.60 Å, whereas that of the 5Ј-GT site (G 5 -T 6 /A 11 -C 12 ) alone is 0.58 Å (Fig. 3 ) (see SI Text for information regarding changes in the local structure of the DNA).
Bithiazole Intercalation and Linker. Comparison of the Co⅐BLM-bound DNA structures revealed two distinct modes of bithiazole intercalation ( Fig. 4 A and B) . When bound to 1, the bithiazole is positioned with its C-terminal thiazole ring stacked between A 10 and A 11 ( Fig. 1B ) and the N-terminal thiazole ring occupying a more central position between the base pairs. This binding mode is stabilized by a water-mediated interaction between the C-terminal thiazole ring N (2.9 Å) and the DNA backbone O4Ј of A 11 (2.9 Å) and another water-mediated interaction between the guanidium NH 2 and the N7 of A 10 that serves to anchor the C-terminal tail within the major groove [NH 2 ⅐⅐⅐H 2 O⅐⅐⅐N7 of A 10 (2.6 Å/3.3 Å)] ( Fig. 4A ; see Table S2 for a complete listing of hydrogen bonding interactions). For the second binding mode observed in 2, the C-terminal thiazole ring is positioned similarly to that of the N-terminal thiazole ring in 1, and its N-terminal ring is stacked between T 7 and T 9 . The carbonyl of the amide linkage within the C-terminal tail in 2 has an equivalent position to the bridging water molecule in 1 ( Fig. 4B ) and may be important for base stacking on either side of the bithiazole. Thus, in 2, the C-terminal tail is not ''fixed'' by hydrogen bonds in the major groove of DNA, because part of the tail is intercalated between the base pairs.
In 1, the position of the fully intercalated bithiazole is equivalent to one base pair step within the DNA, whereas that in 2 is Ϸ0.5 Å shorter (1: T 6 -A 11 rise was 5.99 Å; 2: T 7 -A 10 rise was 5.48 Å). Adjustments in rise upon intercalation are concurrent with DNA unwinding of the helix 3Ј to the 5Ј-GT recognition site. The helix of 1 is unwound at the intercalation site by 8.9°(helical twist of T 6 -A 11 step in unbound 36.0°vs. bound 27.1°), whereas the equivalent site in 2 is unwound by only 4.7°(helical twist of T 7 -A 10 step in unbound 33.1°vs. bound 28.4°).
For the binding mode observed in 1, the linker moiety of Co⅐BLM is well ordered and makes specific hydrogen-bonding interactions with the sugar-phosphate backbone (Fig. 4A) . These interactions include the methyl valerate ϪOH to the O3Ј of T 6 (2.8 Å) and the bithiazole NH (amide linkage to Thr) to the O4Ј of T 7 (3.2 Å) (Fig. 4A) . No specific interactions were observed between the DNA and the ␤-OH of Thr.
Metal-Binding Domain and Disaccharide. A distorted square pyramidal arrangement for the metal binding domain is observed in 1 with the imidazole, deprotonated His amide, pyrimidine N1, and the secondary amine of the ␤-aminoalanine bound as equatorial ligands and the primary amine as an axial ligand to Co(III) (Fig. 5 and Table S3 ). Another proposed ligand, the ␣-D-mannose carbamoyl amide (25) , is 6.2 Å from the Co(III) and interacts with the minor groove of the DNA in our structure. No electron density was observed for the hydroperoxide ligand. Although the bithiazole is well ordered with an average B-factor a ribbon rendering in blue. RT residues Asp-114, Leu-115, Arg-116, and Lys-120 make contacts with the DNA and are shown in black ball-and-stick models. When bound to 1, the metal-binding domain and disaccharide moieties partially stack against each other and display basespecific hydrogen bonding to each respective wall of the minor groove ( Fig. 5 and Table S2 ): pyrimidine N3 to N2 of G 5 (3.1 Å), the pyrimidine C4-NH 2 to N3 of G 5 (2.4 Å), and the ␣-Dmannose carbamoyl NH 2 to O2 of T 13 (2.8 Å). Contacts with the sugar-phosphate backbone include pyrimidine C4-NH 2 to O4Ј of G 5 (2.8 Å) and the ␣-D-mannose C2-OH to O3Ј of A 14 (2.5 Å). Intramolecular hydrogen bonds within DNA-bound Co⅐BLM (Fig. 5) include the ␣-D-mannose carbamoyl carbonyl to the NH 2 of ␤-aminoalanine (3.1 Å), the ␣-D-mannose C4-OH to the carbonyl of the pyrimidine moiety (2.8 Å), and the ␤-aminoalanine NH 2 to the ␤-O of His (3.4 Å). Together, the interactions of the metal-binding domain and disaccharide with the minor groove bury a surface area of 818 Å 2 , whereas the interaction between the ␣-D-mannose moiety, and the metal-binding domain buries 295 Å 2 . Based on coordination constraints and comparison with NMR-derived structural models (23, 24) , a model of the hydroperoxide ligand places the distal oxygen 2.5 Å from the C4Ј atom of T 6 and the coordinating oxygen 4.7 Å from the same C4Ј atom (Fig. 5) ; this finding is entirely consistent with the observations published in refs. 21, 23, and 24.
Discussion
Despite study over the past 40 years, important aspects of the structural organization of metallobleomycin and its interactions with DNA have yet to be resolved. The mode of interaction of the bithiazole with DNA, i.e., minor groove binding (31, 32) vs. full intercalation and/or partial intercalation, has been the subject of debate. In our studies, we find no evidence of minor groove binding by the bithiazole. Rather, we observed two distinct modes of full intercalation for the bithiazole at the site directly 3Ј to the 5Ј-GT recognition site. In addition, we find that bithiazole intercalation occurs independently of well ordered binding of the metal-binding domain in the minor groove as in 2.
In 2D NMR-based models, hydrogen-bonding interactions between the Thr-NH and methylvalerate-NH of the linker and the penultimate oxygen of the metal-bound peroxide have been proposed to play an important role in preorganizing the structure of HOO-Co(III)⅐bleomycin (21, 23, 24) . However, these same linker amides in our structure point away from the penultimate oxygen of the hydroperoxide and are therefore not positioned to hydrogen bond to the hydroperoxide ligand (Fig.  S1, Fig. S2, and Fig. S3) . Instead, the methylvalerate OH and the bithiazole NH hydrogen bond to the DNA (Fig. 4A) . Our findings indicate that interactions between the linker and the DNA rather than interactions of the linker with the hydroperoxide ligand stabilize the binding of HOO-Co(III)⅐bleomycin. Intramolecular hydrogen-bonding interactions within HOOCo(III)⅐bleomycin discussed above also differ from those observed in the previously reported NMR structures.
The metal-coordinating ligands and screw sense within the metal-binding domain of bleomycin have long been a source of debate (33) . The screw sense and Co(III)-coordinating atoms observed in our structure are the same as those proposed in the NMR structures of HOO-Co(III)⅐bleomycin bound to DNA (21, 23, 24) , although the structures clearly differ in detail (Figs.  S1-S3 ). More recently, the primary amine of ␤-aminoalanine has been identified definitively as an axial ligand to Co(III) (34) consistent with earlier models (21, 23, 24) .
In NMR derived models, neither the ␣-D-mannose nor the gulopyranose make direct contacts with the DNA (21, 23, 24) . In our structure, no interactions were observed between the gulopyanose moiety and the DNA, but the ␣-D-mannose carbamoyl NH 2 hydrogen-bonds to the O 2 of T 13 in the minor groove. Thus, no functional role for the gulopyranose can be assigned based on structural analysis. Nonetheless, an important role for the disaccharide moiety in DNA-binding and cleavage by HOOFe(III)⅐bleomycin has been indicated by the reduced DNA cleavage activity of deglycobleomycin in vitro (35, 36) . One possibility is that the gulopyranose serves as a ''space-filling'' unit allowing the metal binding domain to adopt an optimized and stabilized orientation relative to the target C4Ј-H. We further note that the respective orientations and intramolecular hydrogen-bonding interactions of the metal-binding and disaccharide domains of Co⅐BLM bound to 1 are similar to those observed in the crystal structure of Cu(II)⅐bleomycin bound to a bleomycin resistance protein (37) (Fig. S1 ). This finding suggests that binding of bleomycin to a protein or DNA inherently favors partial stacking of the metal binding domain and disaccharide moieties facilitated by intramolecular hydrogen bonding interactions.
The interactions described above all serve to bring the reactive metal center of metallobleomycin into close proximity to a target C4Ј-H. Recent experimental and theoretical studies suggest that HOO-Fe(III)⅐bleomycin induces single strand DNA breaks through abstraction of the C4Ј-H with concerted cleavage of the OOO bond (38) . Based on our structural analysis, we propose that HOO-Fe(III)⅐bleomycin adopts a similar structural arrangement to that found in our model of HOO-Co(III)⅐bleomycin bound to DNA facilitating abstraction of the C4Ј-H by the distal oxygen of the hydroperoxide, which is appropriately positioned in our model to effect this chemistry.
Methods
Crystallization. The RT fragment (residues 24 -278) (29) and DNA oligonucleotides were purified and RT-DNA crystals were grown as described in ref. 27 . Co⅐BLM was prepared from bleomycin B 2 (Calbiochem), metallated as described in refs. 21 and 39, purified by HPLC, and verified by LC-MS. For Co⅐BLM soaks, crystals were soaked in well solutions containing 0.1 mM Co⅐BLM followed by stabilization in 9% PEG 4000, 5 mM magnesium acetate, 100 mM Hepes (pH 8.0), and 20% ethylene glycol containing 0.25 mM Co⅐BLM until unit cell changes were detected.
Data Collection and Refinement. Data were collected at beamline 19-ID of the Advanced Photon Source and integrated and processed with the HKL2000 package (40) . Crystal structures were determined by molecular replacement with AMoRe (41), using the refined model of the N-terminal fragment of MMLV RT as the search model (PDB ID code 1ZTW) to obtain unbiased electron density of the DNA and drug. Coordinates for the B-form model of the desired DNA sequence were generated by using Nucleic Acid Builder (42) and adjusted manually to fit the electron density, using O (43). After addition of water molecules, Co⅐BLM was modeled into the density map starting with a composite model of the drug obtained from 2D NMR (24) and crystallographic data (32) . Our initial F o-Fc map displayed good density for the intercalated bithiazole domain and metal-binding domain and some density for the disaccharide (Fig. S4) . The drug was modeled in parts starting with the bithiazole domain and C-terminal tail, followed by the metal-binding domain, the Thr-methylvalerate linker region to connect the two, and further addition of the disaccharide. A trans conformation of the bithiazole moiety was confirmed in the difference maps. Alternate cycles of model building, using O (43), and refinement calculations in CNS (44) were completed until no large peaks remained in the F o-Fc electron density maps. The final Co⅐BLM model was verified by using SA omit map analysis (44) . A summary of the refinement statistics is shown in Table S1 . DNA structural parameters were analyzed by using 3DNA (45) . Surface area calculations were performed by using NACCESS (46). Figures were generated by using MOLSCRIPT (47) and RASTER 3D (48, 49) . Coordinates for the hydroperoxide model are available upon request.
